Literature DB >> 2915903

The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci.

I U Ali1, G Merlo, R Callahan, R Lidereau.   

Abstract

The int-2 gene, a member of the fibroblast growth factor (FGF) super-gene family, has previously been shown to be amplified in 16% of the 110 human breast tumors examined. In order to characterize the amplification unit containing the int-2 gene (chromosome 11q13), the same panel of breast tumors was screened for possible amplifications of other markers mapping between 11q11 and 11q24. Out of the eight additional genes analysed, simultaneous amplification of bcl-1 (11q13, a locus involved in hematopoietic malignancies) and hst (11q13, another member of the FGF family) was observed in 17/18 tumors with increased copy number of the int-2 gene. A single breast tumor showed amplification of int-2 oncogene only. Neither the bcl-1 nor the hst locus was individually amplified in any of the tumor DNAs examined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2915903

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  Prognostic significance of c-erb-B2 amplification in fine-needle biopsies of breast cancer patients not operated at diagnosis.

Authors:  U Lönn; S Lönn; B Nilsson; B Stenkvist
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Current Topics of Optogenetics for Medical Applications Toward Therapy.

Authors:  Toshihiro Kushibiki
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Expression of activated oncogenes in the murine mammary gland: transgenic models for human breast cancer.

Authors:  W J Muller
Journal:  Cancer Metastasis Rev       Date:  1991-10       Impact factor: 9.264

4.  Loss of heterozygosity for alleles on chromosome II in cervical carcinoma.

Authors:  E S Srivatsan; B C Misra; M Venugopalan; S P Wilczynski
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

5.  Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast.

Authors:  J F Simpson; D E Quan; F O'Malley; T Odom-Maryon; P E Clarke
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

Review 6.  Chromosomal abnormalities in human breast cancer.

Authors:  W M Mars; G F Saunders
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

7.  Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.

Authors:  E A Musgrove; J A Hamilton; C S Lee; K J Sweeney; C K Watts; R L Sutherland
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

8.  Binary system for regulating transgene expression in mice: targeting int-2 gene expression with yeast GAL4/UAS control elements.

Authors:  D M Ornitz; R W Moreadith; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

Review 9.  Genetic alterations in primary breast cancer.

Authors:  R Callahan
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

10.  No difference in CCND1 gene expression between breast cancer patients with and without lymph node metastasis in a Southern Brazilian sample.

Authors:  L B L Maia; F S C Breginski; T C S Cavalcanti; R L R de Souza; V M S Roxo; E M S F Ribeiro
Journal:  Clin Exp Med       Date:  2015-09-26       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.